128 related articles for article (PubMed ID: 2521495)
1. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
2. Expression of human lymphocyte antigen (HLA)-DR on tumor cells in basal cell carcinoma.
Kohchiyama A; Oka D; Ueki H
J Am Acad Dermatol; 1987 Apr; 16(4):833-8. PubMed ID: 2952686
[TBL] [Abstract][Full Text] [Related]
3. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
Hua LA; Kagen CN; Carpenter RJ; Goltz RW
Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
[TBL] [Abstract][Full Text] [Related]
4. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
Feinmesser M; Sulkes A; Morgenstern S; Sulkes J; Stern S; Okon E
J Clin Pathol; 2000 Apr; 53(4):286-91. PubMed ID: 10823125
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the mononuclear infiltrate in Bowen's disease (squamous cell carcinoma in situ). Evidence for a T cell-mediated anti-tumour immune response.
Habets JM; Tank B; van Joost T
Virchows Arch A Pathol Anat Histopathol; 1989; 415(2):125-30. PubMed ID: 2500767
[TBL] [Abstract][Full Text] [Related]
6. beta-2-microglobulin in benign and malignant adnexal skin tumors and metastasizing basocellular carcinomas.
Kallioinen M; Dammert K
J Cutan Pathol; 1984 Feb; 11(1):27-34. PubMed ID: 6365986
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotyping of skin cells during healing of suction blister injury.
Reusch MK; Mansbridge JN; Nickoloff BJ; Morhenn VB
Dermatologica; 1991; 183(3):179-83. PubMed ID: 1683839
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
9. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the mononuclear infiltrate in basal cell carcinoma: a predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
J Invest Dermatol; 1988 Mar; 90(3):289-92. PubMed ID: 3257999
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
Rossen K; Hou-Jensen K; Werdelin O
Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
13. HLA molecules in basal cell carcinoma of the skin.
Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva MR; Ruiz-Cabello F; Serrano S; Garrido F
Immunobiology; 1992 Sep; 185(5):440-52. PubMed ID: 1452215
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of HLA heavy chain and light chain (beta 2 microglobulin) expression on the cell surface of cutaneous malignancies.
Mauduit G; Turbitt M; MacKie RM
Br J Dermatol; 1983 Oct; 109(4):377-81. PubMed ID: 6414503
[TBL] [Abstract][Full Text] [Related]
15. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
[TBL] [Abstract][Full Text] [Related]
16. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
17. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.
Nestle FO; Burg G; Fäh J; Wrone-Smith T; Nickoloff BJ
Am J Pathol; 1997 Feb; 150(2):641-51. PubMed ID: 9033277
[TBL] [Abstract][Full Text] [Related]
18. Beta-2-microglobulin in basal cell carcinoma.
Tjernlund UM; Forsum U
Acta Derm Venereol; 1977; 57(6):503-6. PubMed ID: 73324
[TBL] [Abstract][Full Text] [Related]
19. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
[TBL] [Abstract][Full Text] [Related]
20. MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma.
Dreno B; Bureau B; Stalder JF; Litoux P
Arch Dermatol; 1990 Nov; 126(11):1454-6. PubMed ID: 2146925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]